Causes and mechanisms of peritoneal fibrosis and possible application of NF-κB inhibitor for prevention and treatment
Peritoneal dialysis is an established form of the renal replacement therapy in patients with end stage renal failure. Continuous Ambulatory Peritoneal Dialysis developed by Moncrief and Popovich in 1975 was a revolutionary event, and contributed much to wide application of that form of treatment in...
Main Authors: | Andrzej Bręborowicz, Kazuo Umezawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Poznan University of Medical Sciences
2019-06-01
|
Series: | Journal of Medical Science |
Subjects: | |
Online Access: | https://jms.ump.edu.pl/index.php/JMS/article/view/352 |
Similar Items
-
Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis
by: Józef Penar, et al.
Published: (2009-04-01) -
Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis
by: Manreet Padwal, et al.
Published: (2016-09-01) -
The Effects of Curcumin on NF-κB Level and Degree of Liver Fibrosis in Rat Liver Fibrosis
by: Supriono, et al.
Published: (2018-12-01) -
Blocking core fucosylation of epidermal growth factor (EGF) receptor prevents peritoneal fibrosis progression
by: Changqing Yu, et al.
Published: (2021-01-01) -
Comparison of Sirolimus and Colchicine Treatment on the Development of Peritoneal Fibrozis in Rats Having Peritoneal Dialysis
by: Tamer Sağıroğlu, et al.
Published: (2015-03-01)